SFDA To Prioritize Raising Standards For Essential Drugs
This article was originally published in PharmAsia News
Executive Summary
China's State FDA will soon release regulations on tightening the monitoring and supervision of the quality of essential drugs, with a focus on raising standards for these items. SFDA officials point out that the implementation of a new national essential drugs system will boost the usage of drugs on the list, thus any slip-up could have serious consequences. The agency demands that local drug administrations should strictly enforce provisions of the upcoming regulations; fully understand the types of essential drugs when the list is released, as well as their status, supervisory objectives and measures; enhance monitoring along the entire pathway of drug R&D, production, distribution and application; and raise the level of scientific management. (Click here for more - Chinese Language)